share_log

Ironwood Pharmaceuticals Analyst Ratings

Ironwood Pharmaceuticals Analyst Ratings

艾恩伍德製藥分析師評級
Benzinga ·  2023/09/28 05:54
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/28/2023 128.45% JMP Securities → $22 Initiates Coverage On → Market Outperform
05/23/2023 97.3% Piper Sandler $16 → $19 Maintains Overweight
08/16/2022 34.99% Wells Fargo $12 → $13 Maintains Equal-Weight
04/22/2022 66.15% Piper Sandler → $16 Initiates Coverage On → Overweight
10/12/2021 45.38% Morgan Stanley $13 → $14 Maintains Equal-Weight
07/16/2021 24.61% Morgan Stanley $11 → $12 Maintains Equal-Weight
02/22/2021 14.23% Morgan Stanley $12 → $11 Maintains Equal-Weight
02/19/2021 14.23% Morgan Stanley $12 → $11 Maintains Equal-Weight
11/06/2020 24.61% Credit Suisse $11 → $12 Maintains Neutral
11/06/2020 24.61% Morgan Stanley $11 → $12 Maintains Equal-Weight
09/30/2020 -6.54% Wells Fargo → $9 Downgrades Overweight → Equal-Weight
08/07/2020 14.23% Morgan Stanley $10 → $11 Maintains Equal-Weight
07/15/2020 3.84% Morgan Stanley $11 → $10 Maintains Equal-Weight
06/01/2020 14.23% Credit Suisse $12 → $11 Maintains Neutral
05/11/2020 14.23% HC Wainwright & Co. $13 → $11 Reiterates → Neutral
05/07/2020 14.23% Morgan Stanley $12 → $11 Maintains Equal-Weight
04/30/2020 55.76% Wells Fargo $16 → $15 Maintains Overweight
04/15/2020 24.61% Morgan Stanley $13 → $12 Maintains Equal-Weight
07/10/2019 — Credit Suisse Assumes → Neutral
03/27/2019 45.38% Morgan Stanley $11 → $14 Upgrades Underweight → Equal-Weight
02/25/2019 45.38% HC Wainwright & Co. $11.5 → $14 Upgrades Sell → Neutral
01/24/2019 34.99% JP Morgan $11 → $13 Upgrades Underweight → Neutral
11/07/2018 — JP Morgan Downgrades Neutral → Underweight
11/07/2018 — Credit Suisse Downgrades Outperform → Neutral
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
09/28/2023 128.45% JMP證券 →$22 開始承保 →市場跑贏大盤
2023年05月23日 97.3% 派珀·桑德勒 $16→$19 維護 超重
08/16/2022 34.99% 富國銀行 $12→$13 維護 等重
04/22/2022 66.15% 派珀·桑德勒 →$16 開始承保 →超重
10/12/2021 45.38% 摩根士丹利 $13→$14 維護 等重
07/16/2021 24.61% 摩根士丹利 $11→$12 維護 等重
02/22/2021 14.23% 摩根士丹利 $12→$11 維護 等重
02/19/2021 14.23% 摩根士丹利 $12→$11 維護 等重
11/06/2020 24.61% 瑞士信貸 $11→$12 維護 中性
11/06/2020 24.61% 摩根士丹利 $11→$12 維護 等重
09/30/2020 -6.54% 富國銀行 →$9 評級下調 超重→等重
08/07/2020 14.23% 摩根士丹利 $10→$11 維護 等重
07/15/2020 3.84% 摩根士丹利 $11→$10 維護 等重
06/01/2020 14.23% 瑞士信貸 $12→$11 維護 中性
05/11/2020 14.23% HC Wainwright公司 $13→$11 重申 →中性
05/07/2020 14.23% 摩根士丹利 $12→$11 維護 等重
04/30/2020 55.76% 富國銀行 $16→$15 維護 超重
04/15/2020 24.61% 摩根士丹利 $13→$12 維護 等重
2019年07月10日 - 瑞士信貸 假設 →中性
2019年03月27日 45.38% 摩根士丹利 $11→$14 升級 重量不足的→等重
2019年02月25日 45.38% HC Wainwright公司 $11.5→$14 升級 賣出→中性
2019年01月24日 34.99% 摩根大通 $11→$13 升級 減重→中性
2018/07/11 - 摩根大通 評級下調 中性→減持
2018/07/11 - 瑞士信貸 評級下調 跑贏→中性

What is the target price for Ironwood Pharmaceuticals (IRWD)?

Ironwood PharmPharmticals(IRWD)的目標價是多少？

There is no price target for Ironwood Pharmaceuticals

鐵木製藥沒有目標價

What is the most recent analyst rating for Ironwood Pharmaceuticals (IRWD)?

Ironwood PharmPharmticals(IRWD)的最新分析師評級是多少？

There is no analyst for Ironwood Pharmaceuticals

Ironwood製藥公司沒有分析師

When is the next analyst rating going to be posted or updated for Ironwood Pharmaceuticals (IRWD)?

Ironwood PharmPharmticals(IRWD)的下一次分析師評級將於何時發佈或更新？

There is no next analyst rating for Ironwood Pharmaceuticals

Ironwood PharmPharmticals沒有下一個分析師評級

Is the Analyst Rating Ironwood Pharmaceuticals (IRWD) correct?

分析師對鐵木製藥(IRWD)的評級正確嗎？

There is no next analyst rating for Ironwood Pharmaceuticals

Ironwood PharmPharmticals沒有下一個分析師評級

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論